Trastuzumab - BNF

trastuzumab  Trastuzumab deruxtecan is a HER2 directed antibody-drug conjugate The humanized IgG1 monoclonal antibody is linked to trastuzumab A drug used alone or with other drugs to treat certain types of breast cancer, stomach cancer, and gastroesophageal junction cancer that are HER2

Intravenous trastuzumab is effective as a single-agent, and in combination with chemotherapy it significantly improves the median time to disease Trastuzumab is a biologic therapy indicated for the treatment of human epidermal growth factor receptor 2 -positive breast cancer and

1 ยาพุ่งเป้า HER2 ที่ตัวรับ HER2 ที่ผิวเซลล์มะเร็ง แบ่งเป็น 2 ชนิด · Monoclonal antibody ออกฤทธิ์นอกเซลล์ ได้แก่ pertuzumab, trastuzumab ( Trastuzumab has also been shown to penetrate an impaired blood–brain barrier to a limited degree, such as during radiotherapy, and intrathecal delivery of